0001437749-23-000915.txt : 20230111
0001437749-23-000915.hdr.sgml : 20230111
20230111214917
ACCESSION NUMBER: 0001437749-23-000915
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230109
FILED AS OF DATE: 20230111
DATE AS OF CHANGE: 20230111
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Schafer Joshua
CENTRAL INDEX KEY: 0001945557
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36913
FILM NUMBER: 23524799
MAIL ADDRESS:
STREET 1: SHUTTLE PHARMACEUTICALS HOLDINGS, INC.
STREET 2: ONE RESEARCH COURT, SUITE 450
CITY: ROCKVILLE
STATE: MD
ZIP: 20850
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: KEMPHARM, INC
CENTRAL INDEX KEY: 0001434647
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 205894398
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1180 CELEBRATION BOULEVARD, SUITE 103
CITY: CELEBRATION
STATE: FL
ZIP: 34747
BUSINESS PHONE: (321) 939-3416
MAIL ADDRESS:
STREET 1: 1180 CELEBRATION BOULEVARD, SUITE 103
CITY: CELEBRATION
STATE: FL
ZIP: 34747
FORMER COMPANY:
FORMER CONFORMED NAME: KEMPHARM INC
DATE OF NAME CHANGE: 20080507
4
1
rdgdoc.xml
FORM 4
X0306
4
2023-01-09
0001434647
KEMPHARM, INC
KMPH
0001945557
Schafer Joshua
C/O KEMPHARM, INC.
1180 CELEBRATION BOULEVARD, SUITE 103
CELEBRATION
FL
34747
1
CCO & EVP, Bus. Development
Stock Option (right to buy)
4.54
2023-01-09
4
A
0
300000
0
A
2033-01-08
Common Stock
300000
300000
D
Grant to the Reporting Person of a stock option under the Issuer's 2023 Employment Inducement Award Plan (the "Plan"). 25% of the shares will vest on January 6, 2024 and the remaining 75% of the shares will vest in equal annual installments thereafter, provided that at the relevant vesting dates such optionee's employment relationship has not been terminated as defined in the Plan. All shares underlying the option will vest in full and become immediately exercisable upon a change of control of the Issuer or if the Reporting Person is terminated without cause or resigns for good reason. The option expires ten years after the date of grant.
/s/ Timothy J. Sangiovanni, Attorney-in-Fact for Joshua Schafer
2023-01-11